Role of microRNA-124-3p/Bax axis in neonatal hypoxic-ischaemic encephalopathy. Issue 1 (1st January 2020)

• Record Type: Journal Article
• Authors: Chen, Aiju; Wang, Jimei; Luo, Fei; He, Yafang
• Is Part Of: Biotechnology, biotechnological equipment. Volume 34:Issue 1(2020)
• Page Start: 163
• Page End: 170
• Publication Date: 2020-01-01
• Subjects: Hypoxic-ischaemic encephalopathy -- miR-124-3p -- Bax -- oxygen and glucose deprivation; Biotechnology -- Periodicals; Biotechnology -- Periodicals; Biotechnology -- instrumentation -- Periodicals; Periodicals; 660.605
• DOI: 10.1080/13102818.2020.1724829
• Languages: English
• ISSNs: 1310-2818

Abstract

Abstract: Neonatal hypoxic-ischaemic encephalopathy (HIE) is a neurological disease that can cause neonatal death. MicroRNA-124-3p (miR-124-3p) plays an important role in the development of various diseases. In this research, our aim was to investigate the potential function of miR-124-3p in regulating HIE and to find the underlying mechanism. Here, we discovered that miR-124-3p expression was reduced and cell apoptosis was increased in HIE rat model group. Interestingly, we identified that B cell lymphoma-2-associated X protein (Bax) was a direct target gene of miR-124-3p and Bax expression was negatively modulated by miR-124-3p in HIE. Functional experiments showed that miR-124-3p expression was reduced and Bax expression was increased in oxygen and glucose deprivation (OGD)-treated neurons. In addition, the cell viability of neurons was decreased and apoptosis was increased after OGD treatment. And miR-124-3p over-expression promoted cell viability and restrained apoptosis of the OGD-treated neurons. All these effects were reversed by Bax over-expression. Our results indicated that over-expression of miR-124-3p attenuated OGD-induced neuronal injury through targeting Bax, suggesting a potential role of miR-124-3p/Bax in the pathophysiology of HIE.